CisplatinAntineoplastic AgentsAlkylating AgentsAntineoplastic Agents, AlkylatingAntineoplastic Agents, PhytogenicLeukemia P388Drug Screening Assays, AntitumorDoxorubicinAmaryllidaceae AlkaloidsNarcissusEllipticinesBibenzylsAntineoplastic Combined Chemotherapy ProtocolsAntibiotics, AntineoplasticTumor Cells, CulturedDrug SynergismPaclitaxelBryostatinsThiadiazinesNeoplasmsCell Line, TumorCell SurvivalDrug Resistance, NeoplasmApoptosisAncitabineEtoposideFluorouracilGalliumDose-Response Relationship, DrugAlkylationDepsipeptidesDrug Administration ScheduleDrug ResistanceLeukemia L1210DNA Damage6-MercaptopurineBleomycinMolecular StructureLung NeoplasmsO(6)-Methylguanine-DNA MethyltransferaseAntimetabolites, AntineoplasticAminoacridinesEpothilonesSarcoma 180CyclophosphamideDrug EvaluationOvarian NeoplasmsCarmustineCamptothecinXenograft Model Antitumor AssaysLactonesMethylnitronitrosoguanidineDaunorubicinProdrugsCell DivisionDrug Evaluation, PreclinicalMethotrexateCell CycleNeoplasms, ExperimentalVincristineMice, NudeNitrogen Mustard CompoundsPlatinumMechlorethamineDNA AdductsMethyl MethanesulfonateDNA RepairTaxoidsCell ProliferationEnzyme InhibitorsTime FactorsDNATreatment OutcomeDacarbazineChlorambucilCell LineBiotransformationNeoplasm TransplantationMacrolidesDrug InteractionsCombined Modality TherapyKineticsMelphalanMitomycinBreast NeoplasmsStilbenesVinblastineHL-60 CellsIfosfamideClinical Trials as TopicEthyl MethanesulfonateCaspasesLeukemiaDeoxycytidineIsoquinolinesGuanineNitrosourea CompoundsColonic NeoplasmsMitomycinsCarboplatin